HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$5.76
Day range
$5.60 - $5.85
Year range
$0.73 - $6.55
Market cap
371.04M USD
Avg Volume
372.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.20M | -53.70% |
Net income | -8.18M | 27.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.52M | -57.41% |
Total assets | 12.86M | -55.60% |
Total liabilities | 136.44M | 12.34% |
Total equity | -123.58M | — |
Shares outstanding | 64.47M | — |
Price to book | -2.95 | — |
Return on assets | -73.73% | — |
Return on capital | -285.42% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.18M | 27.06% |
Cash from operations | -3.54M | 58.51% |
Cash from investing | — | — |
Cash from financing | 1.30M | -87.04% |
Net change in cash | -2.25M | -253.63% |
Free cash flow | -3.14M | 49.46% |
About
Founded
2000
Headquarters
Website
Employees
15
